Article
Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodies.
Journal of clinical microbiology - 1 Aug 2005
Lin Sansan, Arcangel Phillip, Medina-Selby Angelica, Coit Doris, Ng Philip, Nguyen Steve, McCoin Colin, Gyenes Alex, Hu Celine, Tandeske Laura, Phelps Bruce, Chien David
Abstract excerpt
The current commercially licensed enzyme-linked immunosorbent assays (ELISAs) for hepatitis C virus (HCV) mainly use recombinant proteins containing linear epitopes. There is evidence, however, that conformational epitopes of HCV are more immunoreactive. Thus, we have designed an HCV antibody assay that employs a conformational protein, NS3NS4a PI (with functional protease and helicase activities), and a linear...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
